Surgeons Tackle Opioid Epidemic With Nationwide Task Force

Posted  Apr 11, 2019 10:33:32 AM

(BOSTON) April 11, 2019 — This month the Americas Hernia Society Quality Collaborative (AHSQC) is launching an Opioid Reduction Task Force to better understand how opioids are prescribed and used by patients. Surgeons who are members of AHSQC can participate in the task force by researching and analyzing patients 30-days after an inguinal or ventral hernia surgery.

The surgeons on this task force will use the data to implement quality improvement projects aimed at reducing the number of opioids prescribed into the population.

“Nearly one out of every 16 patients who receive a postoperative opioid prescription becomes dependent on it for six months. In my own patient research, I found that none of my patients were taking opioid prescriptions 1-2 weeks after surgery and those who did take opioids needed four pills or less” states Dr. Michael Reinhorn of Boston Hernia and Chair of Opioid Reduction Task Force.

Dr. Reinhorn continues, “in my opinion, patients don’t need the quantity of opioid prescriptions that doctors continue to prescribe – which is why we need to educate surgeons through this task force.”

The Opioid Reduction Task Force will be lead by Dr. Michael Reinhorn from Boston Hernia. Dr. Reinhorn has worked with founders of AHSQC, Dr. Benjamin Poulose and Dr. Michael Rosen, to bring the task force to fruition. Dr. Reinhorn will lead surgeons on the task force in conversations around data and findings while informing others in the industry on how they can join and get involved with opioid reduction.

About Michael Reinhorn

Michael Reinhorn has a Bachelor of Science in Engineering from Cornell University, his Doctor of Medicine degree from Boston University School of Medicine, and a Master’s of Business Administration from Brandeis Heller School for Social Policy and Management. He completed his surgical residency at Boston University in 2001 and has since won 22 awards and contributed to at least five publications in the medical industry.